A method to enhance the hit ratio by a combination of structure-based drug screening and ligand-based screening

Original Research

(2881) Views  (753) Full article downloads

Authors: Katsumi Omagari, Daisuke Mitomo, Satoru Kubota, Haruki Nakamura, Yoshifumi Fukunishi

Published Date August 2008 Volume 2008:1 Pages 19 - 28

DOI: http://dx.doi.org/10.2147/AABC.S3767

Katsumi Omagari^1,5, Daisuke Mitomo¹, Satoru Kubota¹, Haruki Nakamura^2,3, Yoshifumi Fukunishi^2,4

¹Japan Biological Informatics Consortium (JBiC), Koto-ku, Tokyo, Japan; ²Biomedicinal Information Research Center (BIRC), National Institute of Advanced Industrial Science and Technology (AIST), Koto-ku, Tokyo, Japan; ³Institute for Protein Research, Osaka University, Suita, Osaka, Japan; ⁴Pharmaceutical Innovation Value Chain, BioGrid Center Kansai, Toyonaka, Osaka, Japan; ⁵Department of Virology, Medical School, Nagoya City University, Mizuho-ku, Nagoya, Japan

Abstract: We examined the procedures to combine two different in silico drug-screening results to achieve a high hit ratio. When the 3D structure of the target protein and some active compounds are known, both structure-based and ligand-based in silico screening methods can be applied. In the present study, the machine-learning score modification multiple target screening (MSM-MTS) method was adopted as a structure-based screening method, and the machine-learning docking score index (ML-DSI) method was adopted as a ligand-based screening method. To combine the predicted compound’s sets by these two screening methods, we examined the product of the sets (consensus set) and the sum of the sets. As a result, the consensus set achieved a higher hit ratio than the sum of the sets and than either individual predicted set. In addition, the current combination was shown to be robust enough for the structural diversities both in different crystal structure and in snapshot structures during molecular dynamics simulations.

Keywords: in silico screening, consensus score, protein-based screening, protein-ligand docking, conformation of active site